Results 201 to 210 of about 9,500,261 (386)
A scalable human iPSC-based neuromuscular disease model on suspended biobased elastomer nanofiber scaffolds. [PDF]
Cheesbrough A +5 more
europepmc +1 more source
Human T cell leukaemia virus type I associated neuromuscular disease causing respiratory failure [PDF]
Edward Littleton
openalex +1 more source
Objective An enduring puzzle in many inherited neurological disorders is the late onset of symptoms despite expression of function‐impairing mutant protein early in life. We examined the basis for onset of impairment in spinocerebellar ataxia type 6 (SCA6), a canonical late‐onset neurodegenerative ataxia which results from a polyglutamine expansion in ...
Haoran Huang +10 more
wiley +1 more source
Diagnosing Neuromuscular Diseases
The field of neuromuscular diseases (NMD) has evolved at an unprecedented speed over the last two decades. Due to advances in molecular genetics, the number of identifiably different diseases has increased and a higher level of complexity has become ...
Alberto L. Dubrovsky
doaj
Decrease of Muscle Mass in Young Patients With Neuromuscular Disease: Assessment of Sarcopenia. [PDF]
Kim J +6 more
europepmc +1 more source
Motion of the Diaphragm in Patients with Chronic Obstructive Pulmonary Disease while Spontaneously Breathing versus during Positive Pressure Breathing after Anesthesia and Neuromuscular Blockade [PDF]
Bruce Kleinman +6 more
openalex +1 more source
Objective Biomarkers with clear contexts of use are important tools for amyotrophic lateral sclerosis (ALS) therapy development. Understanding their longitudinal trajectory in the untreated state is key to their use as potential markers of pharmacodynamic response.
Oleksandr Dergai +16 more
wiley +1 more source
Muscle biopsy practices in the evaluation of neuromuscular disease: A systematic literature review. [PDF]
Ross L +5 more
europepmc +1 more source

